Mantle Cell Lymphoma Pipeline Report Introduction 2. Mantle Cell Lymphoma Pipeline Report Executive Summary 3. Mantle ...

CS Genetics, an innovative genomics technology company, today announced a strategic partnership with ROSALIND®, the premier SaaS platform empowering life science research across diverse technologies.

The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor ... This overexpression contributes to tumor cell proliferation through cell cycle dysregulation, ...

Sickle cell disease causes severe pain that’s hard to treat, but researchers are finding new ways to offer relief ...

“The POD1UM-303/InterAACT2 trial is the first and largest Phase 3 trial evaluating a checkpoint inhibitor for the treatment of patients with squamous cell anal carcinoma ... or placebo during each ...

Halotestin also augments training by improving red blood cell production ... overall nitrogen cycle stability. Halotestin is versatile, used either solo during cutting cycles or in combination with ...

Docetaxel remains the standard of care for patients with 2L/3L NSCLC without targetable alterations despite severe neutropenia (>40%) that greatly impair patients’ quality of life. Six recent phase 3 ...

The therapy is currently in Phase I/Ib clinical development for patients with relapsed/refractory multiple myeloma.

The luteal phase happens after ovulation before bleeding (menstruation) begins. Learn to detect changes in how you feel as ...

Stockmoney Lizards shared key insights into Bitcoin’s market cycle phases and thinks we're in the last weeks of halving correction. He noted that the traders are buying the tops and selling the ...

Brainstorm Cell Therapeutics is pursuing a multi-step ... and it has reported favorable findings. In a US phase 2 study in 48 ALS patients, the company not only achieved its primary endpoint ...